Your invitation to attend the CRS Product Development Forum - Poorly Soluble Drugs

CRS Product Development Forum – Poorly Soluble Drugs

January 27-28, 2011
Doral Golf Resort & Spa
Miami, Florida U.S.A.

You are invited to attend an informative two-day program devoted exclusively to the topic of poorly soluble drugs; CRS Product Development Forum – Poorly Soluble Drugs. January 27-28, 2011, Doral Golf Resort & Spa, Miami, Florida.

Who should attend? People from all fields involved in the development of drugs including receptor targets; drug discovery; ADME; pre-formulation (and formulation); human physiology; and in-vitro, in-silico, and in-vivo models and clinical trials (including special populations).

Understanding the Challenges of Poorly Soluble Drugs
Poorly soluble compounds compose an increasingly large percentage of the NCEs being developed today. These substances have great potential, but they present many challenges to effective delivery, including decreased bioavailability and inter-patient variability. Compounding these issues, many of the existing paradigms for drug development do not apply to poorly soluble compounds.

Unlocking the Door to New Paradigms in Drug Delivery
In spite of these challenges, the potential of poorly soluble drugs is too great to be ignored. By developing new formulation strategies, better technologies for enhancing drug solubility, and more efficient methods of delivery, we can extend the life cycle of established low-solubility drugs, increase the number of poorly soluble drug candidates for development, and deliver highly effective and economically efficient treatments to the patient.

This two-day forum will expose those involved in the discrete parts of the process to state-of-the-art information in all areas. With greater understanding of the full spectrum of problems, we can unlock the door to new paradigms in the development and delivery of poorly soluble drugs, to the benefit of patients and the industry. Register now!

This year, the CRS Product Development Forum is co-located with the 15th Annual Drug Delivery Partnerships, January 26-28, 2011, also at Doral. Ask about registration discounts when registering for both meetings.

PROGRAM HIGHLIGHTS

Plenary Topics
Pros & Cons of BSC in Drug Discovery
Formulation Strategies for Delivering Poorly Soluble Actives
Formulation Strategies with Emphasis on Class 4 Compounds—Good Case Stories
Lipolysis Modeling and Food Effect

Session Topics
Human GI Physiology
In-Vivo Studies of Absorption of Poorly Soluble Actives
Solution/Semi-solid Formulation Approaches
In-Vitro Methodologies
Mid- to Late-State Development (Phase II and Beyond)

Click here to view the complete program with confirmed speakers.

CALL FOR PAPERS
October 29, 2010, is the last day to submit your abstract.

REGISTRATION
The registration deadline is January 4, 2011. Register today!

Share this article with your social network, just click below to share now!

Share |